This scoping review collates evidence for sex biases in the receipt of bystander cardiopulmonary resuscitation (BCPR) among patients with out‐of‐hospital cardiac arrest patients globally. The MEDLINE, PsycINFO, CENTRAL, and Embase databases were screened for relevant literature, dated from inception to March 9, 2022. Studies evaluating the association between BCPR and sex/gender in patients with out‐of‐hospital cardiac arrest, except for pediatric populations and cardiac arrest cases with traumatic cause, were included. The review included 80 articles on BCPR in men and women globally; 58 of these studies evaluated sex differences in BCPR outcomes. Fifty‐nine percent of the relevant studies (34/58) indicated that women are less likely recipients of BCPR, 36% (21/58) observed no significant sex differences, and 5% (3/58) reported that women are more likely to receive BCPR. In other studies, women were found to be less likely to receive BCPR in public but equally or more likely to receive BCPR in residential settings. The general reluctance to perform BCPR on women in the Western countries was attributed to perceived frailty of women, chest exposure, pregnancy, gender stereotypes, oversexualization of women's bodies, and belief that women are unlikely to experience a cardiac arrest. Most studies worldwide indicated that women were less likely to receive BCPR than men. Further research from non‐Western countries is needed to understand the impact of cultural and socioeconomic settings on such biases and design customized interventions accordingly.
Objectives: The aim of this study is to evaluate the effect of mixed reality (MR)‐assisted percutaneous nephrolithotomy (PCNL) on stone‐free rate (SFR), perioperative complications and operative efficiency. Methods: A search of PubMed, Embase and Web of Science from inception to February 2026 followed PRISMA guidelines. Studies comparing MR‐assisted versus standard fluoroscopic or ultrasound‐guided PCNL were included. Risk of bias was assessed using RoB2 and ROBINS‐I. Random‐effects meta‐analyses calculated standardized mean differences (SMD) or risk ratios (RR) with 95% confidence intervals (CI). Results: Nine studies ( n = 774; 378 MR‐assisted, 396 control) met inclusion criteria; eight studies ( n = 730; 356 MR‐assisted, 374 control) were included in meta‐analysis. MR modalities included immersive virtual reality (VR) planning, holographic MR and CT‐ultrasound (US) fusion navigation. The MR‐assisted group had modest improvements in SFR compared to the control group (RR = 1.09; 95% CI 1.00–1.18; p = 0.044; I2 = 17.3%, p = 0.29). Complication rates were similar between MR‐assisted and standard approaches. There was no statistically significant difference in puncture time between MR‐assisted and standard groups (SMD = −0.64; 95% CI −2.22 to 0.93; p = 0.42), with considerable heterogeneity. Similarly, there was no statistically significant difference in operative duration (SMD = −0.22; 95% CI ‐0.66 to +0.23; p = 0.34). While not meeting the threshold for pooled meta‐analysis, narratively, we found that MR‐assistance also reduced puncture attempts, blood loss and fluoroscopy time. Conclusions: MR‐assisted PCNL is associated with an apparent increase in SFR while maintaining comparable operative parameters and complication rates compared with standard techniques. Heterogeneity in these technologies and their applications limits generalizability. Larger, adequately powered standardized trials are recommended to interrogate key outcome measures including SFR and complication rates.